<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:27:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8862538" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8862538</identifier>
        <datestamp>2022-02-23</datestamp>
        <setSpec>bmcpsyc</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Psychiatry</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Psychiatry</journal-id>
              <journal-title-group>
                <journal-title>BMC Psychiatry</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1471-244X</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8862538</article-id>
              <article-id pub-id-type="pmcid">PMC8862538</article-id>
              <article-id pub-id-type="pmc-uid">8862538</article-id>
              <article-id pub-id-type="pmid">35189848</article-id>
              <article-id pub-id-type="publisher-id">3675</article-id>
              <article-id pub-id-type="doi">10.1186/s12888-021-03675-4</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A pragmatic randomized controlled trial of a group self-management support program versus treatment-as-usual for anxiety disorders: study protocol</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9929-8393</contrib-id>
                  <name>
                    <surname>Roberge</surname>
                    <given-names>Pasquale</given-names>
                  </name>
                  <address>
                    <email>Pasquale.Roberge@USherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Houle</surname>
                    <given-names>Janie</given-names>
                  </name>
                  <address>
                    <email>Houle.Janie@uqam.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Provost</surname>
                    <given-names>Jean-Rémy</given-names>
                  </name>
                  <address>
                    <email>Jean-Remy.Provost@monrelief.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coulombe</surname>
                    <given-names>Simon</given-names>
                  </name>
                  <address>
                    <email>Simon.Coulombe@rlt.ulaval.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Beaudin</surname>
                    <given-names>Annie</given-names>
                  </name>
                  <address>
                    <email>Annie.Beaudin@monrelief.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bower</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <address>
                    <email>Peter.Bower@manchester.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lemyre</surname>
                    <given-names>Félix Camirand</given-names>
                  </name>
                  <address>
                    <email>Felix.Camirand.Lemyre@USherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Drapeau</surname>
                    <given-names>Martin</given-names>
                  </name>
                  <address>
                    <email>Martin.Drapeau@mcgill.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Drouin</surname>
                    <given-names>Marc-Simon</given-names>
                  </name>
                  <address>
                    <email>Drouin.Marc_Simon@uqam.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hudon</surname>
                    <given-names>Catherine</given-names>
                  </name>
                  <address>
                    <email>Catherine.Hudon@USherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Provencher</surname>
                    <given-names>Martin D.</given-names>
                  </name>
                  <address>
                    <email>Martin.Provencher@psy.ulaval.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vasiliadis</surname>
                    <given-names>Helen-Maria</given-names>
                  </name>
                  <address>
                    <email>Helen-Maria.Vasiliadis@usherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution>Department of Family Medicine and Emergency Medicine, Faculty of Medicine and Health Sciences, </institution><institution>Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Université de Sherbrooke, </institution></institution-wrap>3001, 12th Avenue North, Sherbrooke (Quebec), J1H 5N4 Canada </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.38678.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 0211</institution-id><institution>Department of Psychology, Faculty of Social Sciences, </institution><institution>Université du Québec à Montréal, </institution></institution-wrap>C.P. 8888, succ. Centre-ville, Montréal (Quebec), H3C 3P8 Canada </aff>
                <aff id="Aff3"><label>3</label>Relief, 418, rue Sherbrooke Est, bur. 300, Montréal (Québec), H2L 1J6 Canada </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.23856.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8390</institution-id><institution>Département des Relations Industrielles, </institution><institution>Université Laval, </institution></institution-wrap>Pavillon J.-A.-DeSève, 1025, avenue des Sciences-Humaines, Québec, G1V 0A6 Canada </aff>
                <aff id="Aff5"><label>5</label>VITAM – Centre de recherche en santé durable, Québec, Canada </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution-id institution-id-type="ISNI">0000000121662407</institution-id><institution>National Institute of Health Research School for Primary Care Research, </institution><institution>The University of Manchester, </institution></institution-wrap>Manchester, M13 9PL UK </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution>Department of Mathematics, Faculty of Sciences, </institution><institution>Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS), Université de Sherbrooke, </institution></institution-wrap>2500, boul. de l’Université, Sherbrooke (Quebec), J1K 2R1 Canada </aff>
                <aff id="Aff8"><label>8</label>Departments of counselling psychology and psychiatry, McGill University, 3700 McTavish, Montreal, Quebec, H3A 1Y2 UK </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.23856.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8390</institution-id><institution>School of Psychology, Faculty of Social Sciences, </institution><institution>Université Laval, </institution></institution-wrap>2325, rue des Bibliothèques, Québec, G1V 0A6 Canada </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution>Centre de recherche Charles-Le Moyne, Department of Community Health Sciences, Faculty of Medicine and Health Sciences, </institution><institution>Université de Sherbrooke, </institution></institution-wrap>3001, 12th Avenue North, Sherbrooke (Quebec), J1H 5N4 Canada </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>2</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>21</day>
                <month>2</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>22</volume>
              <elocation-id>135</elocation-id>
              <history>
                <date date-type="received">
                  <day>13</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>24</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">The integration of a personal recovery-oriented practice in mental health services is an emerging principle in policy planning. Self-management support (SMS) is an intervention promoting recovery that aims at educating patients on the nature of their mental disorder, improving their strategies to manage their day-to-day symptoms, fostering self-efficacy and empowerment, preventing relapse, and promoting well-being. While SMS is well established for chronic physical conditions, there is a lack of evidence to support the implementation of structured SMS programs for common mental disorders, and particularly for anxiety disorders. This study aims to examine the effectiveness of a group-based self-management support program for anxiety disorders as an add-on to treatment-as-usual in community-based care settings.</p>
                </sec>
                <sec>
                  <title>Methods/design</title>
                  <p id="Par2">We will conduct a multicentre pragmatic randomized controlled trial with a pre-treatment, post-treatment (4-month post-randomization), and follow-ups at 8, 12 and 24-months.</p>
                </sec>
                <sec>
                  <title>Treatment and control groups</title>
                  <p id="Par3">a) group self-management support (10 weekly 2.5-h group web-based sessions with 10–15 patients with two trained facilitators); b) treatment-as-usual. Participants will include adults meeting DSM-5 criteria for Panic Disorder, Agoraphobia, Social Anxiety Disorder, and/or Generalized Anxiety Disorder. The primary outcome measure will be the <italic>Beck Anxiety Inventory</italic>; secondary outcome measures will comprise self-reported instruments for anxiety and depressive symptoms, recovery, self-management, quality of life, and service utilisation.</p>
                </sec>
                <sec>
                  <title>Statistical analysis</title>
                  <p id="Par4">Data will be analysed based on intention-to-treat with a mixed effects regression model accounting for between and within-subject variations in the effects of the intervention.</p>
                </sec>
                <sec>
                  <title>Discussion</title>
                  <p id="Par5">This study will contribute to the limited knowledge base regarding the effectiveness of structured group self-management support for anxiety disorders. It is expected that changes in patients’ self-management behaviour will lead to better anxiety management and, consequently, to improved patient outcomes.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par6">ClinicalTrials.gov: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT05124639">NCT05124639</ext-link>. Prospectively registered 18 November 2021.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Anxiety disorders</kwd>
                <kwd>Self-management support</kwd>
                <kwd>Pragmatic trial</kwd>
                <kwd>Group intervention</kwd>
                <kwd>Web-based intervention</kwd>
                <kwd>Transdiagnostic</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id>
                      <institution>Canadian Institutes of Health Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>PJT-169163</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Roberge</surname>
                      <given-names>Pasquale</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <sec id="Sec2">
                <title>Background and rationale</title>
                <p id="Par32">Anxiety disorders are prevalent and disabling mental disorders characterized by marked fear, anxiety and avoidance behavior [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. More frequent in women than men, they often appear during childhood and adolescence, and 50–80% of cases are comorbid with other anxiety disorders, mood disorders, and substance use disorders [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. They also frequently coexist with chronic physical illness [<xref ref-type="bibr" rid="CR8">8</xref>]. Individuals with anxiety disorders demonstrate significant psychological distress, functional and social impairment, suicide risk, and service utilization [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. The Global Burden of Disease Study ranks anxiety disorders as the sixth leading cause of years of life lived with disability [<xref ref-type="bibr" rid="CR14">14</xref>]. Pharmacological and psychological treatments are recommended in clinical practice guidelines for the management of anxiety disorders [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. However, anxiety disorders often present a relapsing or chronic course [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR20">20</xref>], and residual symptoms are frequent, even among patients in remission [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Thus, individuals have an active role to play in their lifelong recovery, beyond the contribution of evidence-based treatments, to develop self-management skills and improve functioning, prevent relapse and live a fulfilling life despite the presence of residual symptoms [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
                <p id="Par33">Self-management support (SMS) is an intervention promoting recovery that aims at educating patients on the nature of their mental disorder, improving their strategies to manage their day-to-day symptoms, fostering self-efficacy and empowerment, preventing relapse and promoting well-being [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. SMS is consistent with patient-centered care [<xref ref-type="bibr" rid="CR28">28</xref>] and has the potential to enhance the efficiency of the health care system for patients by improving health outcomes and reducing overall service utilization [<xref ref-type="bibr" rid="CR29">29</xref>]. SMS is a promising avenue towards recovery by fostering social inclusion, self-determination, autonomy, hope, and personal responsibility. Recovery is defined by the Mental Health Commission of Canada [<xref ref-type="bibr" rid="CR30">30</xref>] as “living a satisfying, hopeful and contributing life, even when there are ongoing limitations caused by mental health problems and illnesses”. Previous studies have found that patients in recovery from anxiety disorders use a large variety of self-management strategies in their day-to-day life to foster their recovery [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. No less than 60 different self-management strategies have been identified in a qualitative study among patients in recovery from mood or anxiety disorders [<xref ref-type="bibr" rid="CR31">31</xref>]. It is expected that changes in patients’ self-management behaviour will lead to better anxiety management and, consequently, to improved patient outcomes, relapse prevention, lower utilization of health care services, and cost savings. SMS typically offers a wide variety of self-management strategies that each person can draw upon based on their needs and preferences to make informed health decisions in their everyday lives, with a predominant focus on self-efficacy, active engagement in the long term, relapse prevention, peer support and facilitation approach. SMS interventions are positioned as a complementary intervention to evidence-based pharmacological or psychological treatments for anxiety disorders and offer a specific contribution to interdisciplinary mental health practice. While some overlap (e.g., psychoeducation, problem solving, relapse prevention) with low-intensity cognitive behavioural therapy (CBT) is acknowledged, a primary difference is that structured SMS programs tend to implement a holistic recovery-oriented approach centered on optimizing wellness and living a fulfilling life even in the presence of ongoing symptoms, to empower people to develop their very own self-management toolbox in a supportive framework, and to be provided by people with a large diversity of backgrounds (e.g., health care providers, social and community workers, peer supporters) [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
                <p id="Par34">While the value of the integration of SMS programs to health care services for chronic physical conditions is well-established [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] and rapidly growing for depression [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], few studies have examined the added value of structured SMS programs for anxiety disorders as a complement to usual care. In a review by Houle et al. [<xref ref-type="bibr" rid="CR25">25</xref>], the efficacy of SMS for depression was examined in six studies and promising results were observed for symptom reduction, self-management behaviours and self-efficacy, and mixed results for relapse rates. A recent literature search identified two other studies, conducted in the United States, that evaluated the efficacy of SMS group interventions, that were both peer-led and administered to heterogeneous samples of patients with mental health problems [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. While promising, most studies did not examine patient outcomes for anxiety disorders. Only two trials were found specifically for self-management support in anxiety disorders. In Germany, a cluster-randomised controlled trial of a nurse-led collaborative care intervention to promote self-management support has shown a small effect on self-efficacy in primary care patients with anxiety, depressive or somatic symptoms [<xref ref-type="bibr" rid="CR38">38</xref>]. In the Netherlands, a randomized controlled trial evaluated a group rehabilitation and self-management program among patients with chronic anxiety and/or depression in an outpatient mental health care setting and reported a moderate effect on empowerment, but did not observe any significant effects on quality of life or symptom severity [<xref ref-type="bibr" rid="CR39">39</xref>]. Consequently, there is a knowledge gap about the added value of structured SMS programs to usual care for common mental disorders, and particularly for anxiety disorders.</p>
                <p id="Par35">A program of self-management workshops for mental health has gathered interest from policy makers, health care managers, clinicians, and patients alike over the past few years. The <italic>J’avance!</italic> program was developed by a well-established mental health community-based organisation in Quebec, Relief (<ext-link ext-link-type="uri" xlink:href="https://monrelief.ca">https://monrelief.ca</ext-link>), whose mission is to help individuals with anxiety disorders, depression, and bipolar disorder. The SMS program designed for anxiety disorders draws on personal recovery models as well as on low-intensity psychosocial and psychological interventions; it has been thoroughly developed in collaboration with researchers (JH; scientific lead) and reviewed by an interdisciplinary expert committee as well as participants from pilot groups. The SMS program covers a broad range of mental health intervention strategies (e.g., problem solving, emotion regulation, exposure, cognitive restructuring, mindfulness) and wellness-focused approaches (e.g., strengths, social support, lifestyle habits) in a non-directive “toolkit” aimed at building self-management skills. Great emphasis is placed on peer support, with participants sharing experiential knowledge, committing to trying self-management strategies and overcoming stigmatization. Since 2014, the SMS intervention was delivered over 445 times and over 1000 facilitators have been trained to date, and implementation is also beginning across Canada and internationally. Initially an on-site only workshop, Relief has implemented in 2020 a virtual delivery format on an eLearning platform and is now conducting group SMS workshops with both modalities. Given this wide-spread implementation, we sought to examine how the group SMS workshop translates into better mental health outcomes, health care system utilization and overall efficiency as a complement to usual care for patients with anxiety disorders.</p>
              </sec>
              <sec id="Sec3">
                <title>Objectives</title>
                <p id="Par36">The aim of the present study is to evaluate the effectiveness of a structured group virtual SMS program as an add-on to treatment-as-usual (TAU) in a sample of adults with anxiety disorders. Primary questions: When group SMS is added to TAU in community-based care for patients with anxiety disorders, is the SMS + TAU group more effective in reducing anxiety symptoms than TAU alone? Secondary questions: a) Considering a recovery-oriented approach for patients with anxiety disorders, is there a significant difference between group SMS + TAU and usual care in terms of self-management strategies and personal recovery assessment at the 12-month follow-up? b) Does group SMS + TAU present superior cost-effectiveness and cost-utility, in terms of quality of life and anxiety-free days, than TAU for patients with anxiety disorders at the 12-months follow-up? c) Is there a significant difference between group SMS + TAU and usual care for high-end functioning rates? d) Is there maintenance of gains at 12- and 24-months follow-up? e) Is there differential effectiveness based on moderators (i.e., sociodemographic characteristics, clinical characteristics, past treatment experience) and mediators (i.e., group cohesion, therapeutic alliance, adherence)?</p>
              </sec>
              <sec id="Sec4">
                <title>Trial design</title>
                <p id="Par37">The trial is a two-arm parallel group multicentre pragmatic superiority randomized controlled trial (RCT), with a 1:1 allocation at the individual level. The group SMS intervention will be offered to participants in the TAU groups after the 12-month follow-up (delayed-intervention). The 24-month follow-up will therefore only provide a within-group dataset. The proposed protocol conforms to SPIRIT guidance [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
              </sec>
            </sec>
            <sec id="Sec5">
              <title>Methods</title>
              <sec id="Sec6">
                <title>Participants, interventions, and outcomes</title>
                <sec id="Sec7">
                  <title>Study setting</title>
                  <p id="Par38">The study will be conducted in four health administrative regions in Quebec (Canada): Eastern townships, Mauricie-et-Centre-du-Québec, Abitibi-Témiscamingue and Laurentides. Administrative regions were purposefully selected based on the following criteria: a) the in-person group SMS intervention is not currently largely implemented in the region; b) the virtual SMS intervention is rarely accessed by participants from the region, even though the virtual SMS format is technically accessible throughout the province; c) diversity (e.g., population size, region, university teaching hospital).</p>
                </sec>
                <sec id="Sec8">
                  <title>Eligibility criteria</title>
                  <p id="Par39">This pragmatic RCT focuses on broad inclusion criteria for mixed anxiety disorders groups and minimal exclusion criteria. <italic>Inclusion criteria:</italic> (1) aged 18 and over, (2) fluent in spoken and written French, (3) meeting DSM-5 diagnostic criteria for at least one of the following anxiety disorders: Panic Disorder, Agoraphobia, Generalized Anxiety Disorder, and Social Anxiety Disorder, (4) access to a computer or tablet connected to the internet with microphone and video camera. <italic>Exclusion criteria:</italic> (1) previous enrolment in the SMS intervention for anxiety disorders provided by Relief, (2) active suicidal intentions, (3) severe depressive symptoms (i.e., PHQ-9 score ≥ 20), (4) active substance-related and addictive disorder, and (5) cognitive impairment.</p>
                </sec>
                <sec id="Sec9">
                  <title>Recruitment</title>
                  <p id="Par40">Recruitment strategies will include self-referral following advertisements (e.g., waiting rooms of clinics, bulletin boards, geo-located website, and social media) and referrals from community-based primary care (e.g., family physician, community organization, mental health care team, mental health provider). The recruitment of participants will be conducted through a two-stage process. <italic>Filter 1:</italic> Self-referred individuals will acquire information on the study by accessing the study’s website or through a telephone call or email to our research laboratory. Self-referred individuals will complete a web-based screening survey comprising the required online consent form, basic eligibility criteria as well as anxiety symptoms and comorbidity overview. The initial web-based consent form and procedure has been approved by the ethics committee. At the end of the survey, they will provide their name and contact information. In the presence of clear exclusion criteria, a list of mental health resources will be provided. <italic>Filter 2:</italic> In the second stage (within 2 weeks of the screening survey), the baseline assessment will be conducted on a secure web-based platform with a trained clinical evaluator. The interview will begin with the consent form. The evaluator will explain the study, review the consent form with the participants, answer their questions, and verbally ask for their consent. The consent form will be sent by email for the participants to read prior to the online assessment, and this verbal consent procedure has been approved by the ethics committee given the web-based data collection method. The assessment will comprise sociodemographic data, service utilization and MINI International Neuropsychiatric Interview [<xref ref-type="bibr" rid="CR41">41</xref>] for DSM-5 assessment (T<sub>0</sub>; random pre-assignment), combined with an adapted baseline Relief interview procedure (e.g., current main difficulties, interest in the program, capacity to use eLearning technology, readiness to take part in a group intervention). Patients meeting eligibility criteria at T<sub>0</sub> will be given instructions to complete the remaining web-based self-reported questionnaires within 48 h, and only then will we have all required information to proceed with randomization. Figure <xref rid="Fig1" ref-type="fig">1</xref> shows the study flowchart.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow of participants</p></caption><graphic xlink:href="12888_2021_3675_Fig1_HTML" id="MO1"/></fig></p>
                </sec>
                <sec id="Sec10">
                  <title>Interventions</title>
                  <sec id="FPar1">
                    <title>Group SMS for anxiety disorders + treatment-as-usual (TAU)</title>
                    <p id="Par41">The SMS manualized program for anxiety disorders (<ext-link ext-link-type="uri" xlink:href="https://monrelief.ca">https://monrelief.ca</ext-link>) aims at improving self-management capabilities through weekly 2.5-h sessions with 10–15 patients over a 10-week period. The SMS program (see Table <xref rid="Tab1" ref-type="table">1</xref>) covers the following themes: getting to know your anxiety; building self-awareness; reconsidering your lifestyle habits; adopting a problem-solving method; avoidance and exposure; acceptance and committed action; seeing things differently; managing your emotions; receiving support from others; and consolidating your toolkit. The trial will focus solely on the virtual format. As in the groups delivered by Relief, SMS will be either co-facilitated by health care professionals (e.g., social worker, psycho-educator, nurse), or by a health care professional and a peer supporter, namely a person recovered from an anxiety disorder who has experience and training offering peer support, building on mutual understanding and respect [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref>], to emphasize experiential knowledge sharing. <italic>Relief</italic> will provide the material for the training of the facilitators, the program documentation, the eLearning platform, and the material used by the participants. Consistent with standard implementation of this SMS program, facilitators will participate in a one-day <italic>Relief</italic> training program. Three case discussions for each group delivered (before onset, mid-group, and following last session) will be conducted by the research team. A random review of 30% of recordings of sessions will be conducted to monitor adherence with a treatment integrity scale. Integrity data will not be used to intervene to improve compliance, but only to examine process-outcome correlation and to guide improvements following the trial. Patient compliance will be supported through the extensive Relief experience delivering SMS (e.g., material, training, support), and the convenient eLearning platform (e.g., easy access, reduced stigma).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Content of the 10-week SMS manualized group program for anxiety disorders</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Week</th><th>Theme</th><th>Content</th></tr></thead><tbody><tr><td>1</td><td>Getting to know your anxiety</td><td><p>• Learn more about anxiety</p><p>• Recognize the signs of anxiety</p></td></tr><tr><td>2</td><td>Building self-awareness</td><td><p>• Develop self-observation skills to better understand your anxiety</p><p>• Understand the function of different resources that are available</p></td></tr><tr><td>3</td><td>Reconsidering your lifestyle habits</td><td><p>• Understand how lifestyle habits influence anxiety</p><p>• Use an action plan to initiate change</p><p>• Learn about mindfulness</p><p>• Incorporate relaxation techniques</p></td></tr><tr><td>4</td><td>Adopting a problem-solving method</td><td>• Learn to put a problem-solving strategy into practice</td></tr><tr><td>5</td><td>Avoidance and exposure</td><td><p>• Understand how avoidance works</p><p>• Learn the exposure technique</p></td></tr><tr><td>6</td><td>Acceptance and committed action</td><td><p>• Understand the acceptance process</p><p>• Take action despite anxiety</p></td></tr><tr><td>7</td><td>Seeing things differently</td><td><p>• Become aware of filters (cognitive distortions)</p><p>• Recognize and mitigate the negative effects filters have on anxiety</p></td></tr><tr><td>8</td><td>Managing your emotions</td><td><p>• Decipher the messages your emotions are sending</p><p>• Become better equipped to manage your emotions</p></td></tr><tr><td>9</td><td>Receiving support from others</td><td><p>• Realize how anxiety influences interpersonal relationships</p><p>• Appreciate the importance of social support</p><p>• Expand your support network</p></td></tr><tr><td>10</td><td>Consolidating your tool kit</td><td><p>• Acknowledge your progress</p><p>• Recognize and consolidate your new skills</p></td></tr></tbody></table></table-wrap></p>
                  </sec>
                  <sec id="FPar2">
                    <title>Treatment-as-usual</title>
                    <p id="Par42">No limitations will be imposed concerning usual care, as we aim at examining the added value of SMS to TAU. To reflect heterogeneity of health seeking behaviour and mental health practices for anxiety disorders in the community, we do not require that participants have a family physician, be constrained to a prespecified usual care or have contacts with the healthcare system. To minimize behavioural change in healthcare providers, we will not inform any healthcare provider of participation in the study. As the intervention will be provided on an eLearning platform, and not embedded in clinics, contact between intervention and control patients is unlikely. All participants will receive information about the SMS intervention and the goal of the study, i.e., “of helping them manage their anxiety”. We will thoroughly assess participant-reported service utilization 12 months prior to enrolment and during the study to examine risk of study-induced behavioral change with regards to usual care.</p>
                  </sec>
                </sec>
                <sec id="Sec11">
                  <title>Participant assessment</title>
                  <p id="Par43">Table <xref rid="Tab2" ref-type="table">2</xref> shows the assessment timeline. The data collection will be based on instruments with good psychometric properties, previously used in clinical trials for anxiety disorders to ensure comparability, and with validated French versions (when available).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Study schedule of patient assessment</p></caption><table frame="hsides" rules="groups"><thead><tr><th>TIMEPOINT</th><th>Web-based screening</th><th>Web-based interview and questionnaires-Enrolment</th><th colspan="5">Intervention</th></tr><tr><th/><th/><th/><th colspan="5">Follow-up</th></tr><tr><th/><th>T<sub><bold>−1</bold></sub></th><th>T<sub><bold>0</bold></sub></th><th/><th>T<sub><bold>1</bold></sub></th><th>T<sub><bold>2</bold></sub></th><th>T<sub><bold>3</bold></sub></th><th>T<sub><bold>4</bold></sub></th></tr></thead><tbody><tr><td colspan="8"><bold>INITIAL SOCIODEMOGRAPHIC AND CLINICAL ASSESSMENT</bold></td></tr><tr><td> Sociodemographic variables</td><td>X</td><td>X</td><td/><td/><td/><td/><td/></tr><tr><td> Social Phobia Inventory</td><td>X</td><td/><td/><td/><td/><td/><td/></tr><tr><td> Panic Disorder Severity Scale</td><td>X</td><td/><td/><td/><td/><td/><td/></tr><tr><td> Mini International Neuropsychiatric Interview (MINI)</td><td/><td>X</td><td/><td/><td/><td/><td/></tr><tr><td> Disease Burden Morbidity Assessment</td><td/><td>X</td><td/><td/><td/><td/><td/></tr><tr><td> Service utilization and medication (past 12 months)</td><td/><td>X</td><td/><td/><td/><td/><td/></tr><tr><td colspan="8"><bold>SYMPTOM-FOCUSED OUTCOMES</bold></td></tr><tr><td> Generalised Anxiety Disorder – 7</td><td>X</td><td/><td/><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td> Beck Anxiety Inventory</td><td/><td>X</td><td/><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td> Patient Health Questionnaire – 9</td><td>X</td><td/><td/><td>X</td><td/><td>X</td><td>X</td></tr><tr><td colspan="8"><bold>RECOVERY-FOCUSED OUTCOMES</bold></td></tr><tr><td> Recovery Assessment Scale - Revised</td><td/><td>X</td><td/><td>X</td><td/><td>X</td><td>X</td></tr><tr><td> Mental Health Self-Management Questionnaire</td><td/><td>X</td><td/><td>X</td><td/><td>X</td><td>X</td></tr><tr><td colspan="8"><bold>ECONOMIC EVALUATION OUTCOMES</bold></td></tr><tr><td> AQoL-6D</td><td/><td>X</td><td/><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td> Service utilization and medication (past 4-months)</td><td/><td>X</td><td/><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td colspan="8"><bold>PROCESS MEASURES</bold></td></tr><tr><td> Working Alliance Inventory</td><td/><td/><td>X</td><td/><td/><td/><td/></tr><tr><td> Gross Cohesion Scale</td><td/><td/><td>X</td><td/><td/><td/><td/></tr><tr><td> Logbook</td><td/><td/><td>X</td><td/><td/><td/><td/></tr><tr><td colspan="8"><bold>EXPERIENCE WITH THE INTERVENTION</bold></td></tr><tr><td> Brief qualitative interview</td><td/><td/><td/><td/><td/><td>X</td><td>X</td></tr></tbody></table></table-wrap></p>
                  <sec id="FPar3">
                    <title>Baseline</title>
                    <p id="Par44">Sociodemographic variables will be collected at baseline (T<sub>−1</sub> et T<sub>0</sub>), and comprise sex and gender, age, marital status, racial identity, ethnicity, education level, income level, occupation, and insurance coverage. We will also collect data on previous experience with mental health services. The web-based screening survey will comprise the Generalised Anxiety Disorder-7 (GAD-7) [<xref ref-type="bibr" rid="CR45">45</xref>], a 7-item self-report questionnaire measuring anxiety symptomatology. Diagnostic-specific measures will also be administered. The Social Phobia Inventory (SPIN) [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>] is a 17-item self-report questionnaire measuring the fear, avoidance, and physiological discomfort associated with social anxiety disorder. Studies have reported good internal reliability, test-retest reliability, and convergent validity [<xref ref-type="bibr" rid="CR46">46</xref>]. The Panic Disorder Severity Scale Self Report (PDSS-SR) [<xref ref-type="bibr" rid="CR48">48</xref>] is a questionnaire measuring the severity of seven dimensions of panic disorder. The PDSS-SR shows good internal reliability, test-retest reliability and sensitivity to change [<xref ref-type="bibr" rid="CR48">48</xref>]. The clinical assessment will be based on the Mini International Neuropsychiatric Interview (MINI) [<xref ref-type="bibr" rid="CR41">41</xref>], a brief structured diagnostic interview for DSM-5 administered by a trained lay interviewer. Inter-rater reliability will be assessed for 25% of audio-recorded interviews.</p>
                  </sec>
                  <sec id="FPar4">
                    <title>Primary outcome measure</title>
                    <p id="Par45">The severity of anxiety symptoms will be assessed using the self-report, 21-item Beck Anxiety Inventory (BAI) [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. The BAI assesses emotional, physiological, and cognitive symptoms of anxiety and indicates minimal (0–7), mild (8–15), moderate (16–25) and severe anxiety (26–63). The scale shows significant reliable improvement and clinically significant change cut-points [<xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR51">51</xref>].</p>
                  </sec>
                  <sec id="FPar5">
                    <title>Secondary outcome measures</title>
                    <p id="Par46">Participants will also complete diagnostic-specific measures, as well as other questionnaires related to quality of life, self-management, and recovery. The Patient Health Questionnaire (PHQ-9) [<xref ref-type="bibr" rid="CR52">52</xref>] is a 9-item, self -report questionnaire measuring the frequency of depressive symptoms with good reliability and validity. The Assessment of Quality of Life – 6D (AQol-6D) [<xref ref-type="bibr" rid="CR53">53</xref>] is a valid and reliable 20-item questionnaire assessing six psychosocial and physical dimensions related to the quality of life. The Disease Burden Morbidity Assessment [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>] is a self-report questionnaire measuring the presence of chronic conditions and interference on daily activities. The self-administered Recovery Assessment Scale – revised (RAS-r) [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR59">59</xref>] is a 24-item validated patient-oriented outcome measure of recovery in five domains: personal confidence and hope, willingness to ask for help, goal and success orientation, reliance on others, no domination by symptoms. The RAS is the most frequently used and tested recovery measure, has good psychometric properties, including sensitivity to change, and correlates with a range of other measures (e.g., activation, psychological well-being, positive illness outlook). The Mental Health Self-Management Questionnaire (MHSQ) [<xref ref-type="bibr" rid="CR23">23</xref>] assesses the use of mental health self-management strategies. It comprises 18 items. The scale has satisfactory internal reliability and construct validity, adequate test–retest reliability and its convergent and concurrent validity are supported.</p>
                  </sec>
                  <sec id="Sec12">
                    <title>Service utilization</title>
                    <p id="Par47">Data will be obtained from provincial administrative databases (i.e., <italic>Régie de l’assurance-maladie du Québec</italic> (RAMQ), Quebec emergency department database (BDCU) and public primary health care database (I-CLSC)) for medical and biopsychosocial services, hospitalization’s registry, and medication data at the end of the data collection. A brief questionnaire on other mental health consultations (e.g., type of professional, duration, costs) and psychotropic medication will be administered at each assessment period to offset the limitations of administrative data.</p>
                  </sec>
                  <sec id="Sec13">
                    <title>Questionnaires completed during SMS sessions</title>
                    <p id="Par48">The appreciation of the alliance for both participants and facilitators will be assessed with the 12-item version of the Working Alliance Inventory (WAI) [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. The WAI shows good construct validity and high internal consistency [<xref ref-type="bibr" rid="CR62">62</xref>]. The perceived cohesiveness and bond for participants will be examined with the 9-item Gross Cohesion Scale (GCS) [<xref ref-type="bibr" rid="CR63">63</xref>], a scale with acceptable reliability and validity. These measures will be used at sessions 3 and 8.</p>
                    <p id="Par49">A logbook will also be used by facilitators to record intervention adherence for each participant as well as to report experiences and perceptions related to SMS group facilitation. The logbook content will provide a better understanding of the actual implementation of the program. The facilitators will also complete a brief questionnaire comprising sociodemographic questions, items on academic and professional backgrounds, as well as experience with SMS, group interventions and anxiety disorders.</p>
                  </sec>
                </sec>
              </sec>
              <sec id="Sec14">
                <title>Embedded qualitative interview</title>
                <p id="Par50">A sequential embedded qualitative approach [<xref ref-type="bibr" rid="CR64">64</xref>] will be used to explore participants’ views and experiences regarding the SMS intervention. The data collection will include a brief individual telephone contact with open-ended questions at the T<sub>3</sub> and T<sub>4</sub> follow-ups. A semi-structured interview guide [<xref ref-type="bibr" rid="CR65">65</xref>] with open-ended questions will be used to elicit information on topics such as participants’ experience with the intervention, its perceived effectiveness, and most useful strategies or skills acquired. We will obtain verbatim transcripts of all the audio recordings. Data coding and analysis will be conducted based on the interactive cyclical process of data reduction, data display and conclusion drawing and verification [<xref ref-type="bibr" rid="CR66">66</xref>]. For data reduction, we will use the QSR*NVIVO database software [<xref ref-type="bibr" rid="CR67">67</xref>] to analyze the transcriptions with a coding strategy based on emerging clustering during the process.</p>
              </sec>
              <sec id="Sec15">
                <title>Data collection, management, and analysis</title>
                <sec id="Sec16">
                  <title>Participant timeline</title>
                  <p id="Par51">The assessments will be conducted at baseline (T<sub>−1</sub>, T<sub>0</sub>), posttreatment (T<sub>1</sub>; 4-month post-randomization) and follow up at 8-month (T<sub>2</sub>), 12-month (T<sub>3</sub>) and 24-month (T<sub>4</sub>) post-randomization. In-treatment assessments for participants and facilitators will also be conducted at sessions 3 and 8. Self-report questionnaires at each assessment period will be completed online through the REDCap application managed at the <italic>Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke</italic> (CRCHUS) at University of Sherbrooke on a secure server with systematic backups. The clinical interviews (T<sub>0</sub>, T<sub>3</sub>, T<sub>4</sub> only) will be conducted with the Zoom video conferencing service. Data collection with the REDCap application will be managed independently of the treatment assignment. The database will only include coded, depersonalised data, and participant’s identifying information will be stored in a separate secure location with restricted access to the linking code.</p>
                  <p id="Par52">We conservatively planned for a 25% attrition at follow up, but we will devote considerable efforts toward a &lt; 5% target with study retention strategies: (1) limiting burden and inconvenience (minimal data collection; web-based; secondary direct data capture through administrative databases); (2) minimal dataset for participants identified at high-risk of attrition (BAI, AQoL-6D); (3) monitoring data collection in real time; (4) education strategies on patient engagement and appreciation (e.g. reminders, website), (5) contact of dropouts; (6) information gathering for relocation; (7) financial compensation (20 $ for each follow up assessment); (8) treatment incentives with delayed-access to SMS for control arm to increase perceived health benefits. Follow up measures at 12- and 24-month are more susceptible to attrition (secondary analysis), and we will include a brief web-based interview that will foster patient engagement. Moreover, we will obtain a complete dataset from provincial administrative data on service utilization.</p>
                </sec>
                <sec id="Sec17">
                  <title>Assignment of interventions: Sequence generation, allocation concealment mechanism and implementation</title>
                  <p id="Par53">Participants will be randomized based on stratification for study site, with random block sizes (2, 4, 6) to ensure a balance in the allocation for the strata. The randomization schema will be carried out using a code generated by the study statistician. Concealment will be maintained for the participants, research team, and staff. The REDCap computerized platform will only release the randomization code to the research coordinator based on the allocation sequence after verification of eligibility. The research coordinator will then enrol and assign participants to interventions.</p>
                  <p id="Par54">The randomization sequence will be recorded with random codes (“A” and “B”) until the primary outcome analyses are concluded. Masking of trial participants and facilitators is not possible in this trial. Clinical evaluations at T<sub>3</sub> and T<sub>4</sub> will not be masked as we will address through qualitative interviews patient experience following the SMS intervention, or readiness to enroll intervention at T<sub>3</sub> for the control group.</p>
                </sec>
                <sec id="Sec18">
                  <title>Sample size</title>
                  <p id="Par55">Due to challenges in calculations for mixed regression models [<xref ref-type="bibr" rid="CR68">68</xref>], we estimated sample size based on the baseline (T<sub>0</sub>) and post-treatment (T<sub>1</sub>) difference between groups for the primary outcome. The sample size was calculated using G*Power with the BAI based on an estimated effect size of the SMS + TAU intervention (Cohen’s <italic>d</italic>) of 0.32 (0.56 intra-group). This corresponds to a 7-point difference based on previous studies [<xref ref-type="bibr" rid="CR51">51</xref>] that have established <italic>clinically significant change</italic> thresholds for the BAI [<xref ref-type="bibr" rid="CR69">69</xref>]; such an effect size at post-treatment for symptom reduction is consistent with previous SMS studies for mental disorders [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>] as well as with pilot data of SMS (conservative estimates). The 3-point difference and SD for the TAU only group are conservative values based on our current data in a similar study with a TAU group [<xref ref-type="bibr" rid="CR70">70</xref>]. A sample size of 155 individuals per group is therefore required to detect a 4-point (pooled SD: 12.5) pre-post treatment difference between SMS + TAU and TAU (i.e., a 7-point difference for SMS + TAU and 3-point for TAU) with an 80% power and α = 0.05. As there is a potential for intraclass correlations (ICC) in an individually randomized group treatment trial [<xref ref-type="bibr" rid="CR71">71</xref>], we also estimated [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>] that based on a mixed model accounting for possible between-individual correlations within each intervention group (ICC of 0.02 for based on a similar study [<xref ref-type="bibr" rid="CR70">70</xref>]), the power would be of at least 76%. With an adjustment for a conservative 25% attrition rate, the proposed sample size is 207 individuals for each treatment arm.</p>
                </sec>
                <sec id="Sec19">
                  <title>Statistical Analyses</title>
                  <sec id="FPar6">
                    <title>Clinical outcomes</title>
                    <p id="Par56">Statistical analysis will follow intent-to-treat principles. The primary outcome analysis will be performed at T<sub>1</sub>. The remaining analysis will be conducted considering all measures over time when all participants have completed the 12-month (T<sub>0</sub> through T<sub>3</sub>) and 24-month follow up (T<sub>0</sub> through T<sub>4</sub>). Primary question: A mixed model regression with the maximum-likelihood method will be performed to consider between- and within-subject variations in the analysis of the longitudinal effects of SMS + TAU compared to TAU on the primary outcome measure (BAI) at post-treatment (T<sub>1</sub>). To control for potential intra-group variability, random effects will be added on the participants nested in the SMS groups. Baseline clinical variables (e.g., anxiety disorders, comorbid depressive symptoms, psychotropic medication, psychotherapy) will be entered in the model as covariates. Analyses will be conducted with all available data without imputation, as estimation of parameters by maximum likelihood is considered adequate to address missing data as post-treatment in the multilevel model [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>].</p>
                    <p id="Par57">For secondary questions, logistic regression models will be used to examine high-end functioning rates. The mixed model regression approach will be repeated on all data at the 12-month (T<sub>0</sub> through T<sub>3</sub>) and 24-month (T<sub>0</sub> through T<sub>4</sub>) follow-up, and will allow for the inclusion of patients with missing data at any of the follow-up assessments (T<sub>1</sub>,T<sub>2</sub>,T<sub>3</sub>,T<sub>4</sub>). Additionally, treatment effect sizes will be estimated with Cohen’s <italic>d</italic>. We will also conduct hypothesis-generating moderator and mediator analysis [<xref ref-type="bibr" rid="CR76">76</xref>]. Moderation analyses will be performed for three sets of moderators, including clinical characteristics (e.g., anxiety disorders at baseline, anxiety severity, comorbid depression), previous treatments (psychotropic medication, psychotherapy) and sociodemographic characteristics (e.g., age group, sex, education level). Mediators will be examined for therapeutic alliance, group cohesion and adherence. Sensitivity analysis will be applied to examine the influence of missing data, and to document <italic>per protocol</italic> treatment effects (≥ 8 sessions completed).</p>
                  </sec>
                  <sec id="FPar7">
                    <title>Economic evaluation outcomes</title>
                    <p id="Par58">The cost-effectiveness and cost-utility analysis will be carried out from health system and patient perspectives based on Canadian guidelines [<xref ref-type="bibr" rid="CR77">77</xref>]. The 2-year costs considered will include all medical services and resources used during hospitalization, emergency department visits, outpatient visits, physician fees and outpatient medications. Patient out-of-pocket costs will include drug co-payments, payments to professionals not covered by the provincial public health insurance coverage, costs related to transportation and time spent by patients while seeking outpatient medical attention, as well as costs related to presenteeism and absenteeism [<xref ref-type="bibr" rid="CR78">78</xref>]. Program costs associated with the training of facilitators and group meetings will include salaries, benefits, institutional overhead, and opportunity costs [<xref ref-type="bibr" rid="CR79">79</xref>]. Generalized linear models (GLM) with log link and appropriate distribution (i.e., gamma) will be used to study the difference in costs (Beta estimates) as a function of the intervention (TAU vs SMS) while controlling for potential confounding study factors. Health outcomes will include symptom reduction (BAI) and health-related multi-attribute utility quality of life (AQoL-6D). The number of Anxiety-Free Days (AFD) will be calculated for each BAI scores with a value between 1 (‘anxiety free’) and 0 (‘fully symptomatic’) with linear interpolation to estimate the number of AFDs between baseline and follow up [<xref ref-type="bibr" rid="CR80">80</xref>]. We will measure quality of life with the AQoL-6D to assess utility estimates [<xref ref-type="bibr" rid="CR81">81</xref>]. For data analyses, repeated measures will be used to assess the difference (Beta estimates) in health outcomes as a function of the intervention and variables of interest. The incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICUR) will be calculated based on beta estimates obtained. A discounting rate of 3.5% will be used for future values. We will carry out a sensitivity analysis for estimated values while considering a range of plausible values (95% CI). The ICUR will quantify the trade-off between costs and health-related quality of life.</p>
                  </sec>
                </sec>
              </sec>
              <sec id="Sec20">
                <title>Trial coordination</title>
                <p id="Par59">The trial coordinating center will be at Université de Sherbrooke. The executive committee will be composed of the principal investigators, the principal knowledge user (or representative), and research coordinator, with web meetings every two to three weeks throughout the four years of the project, an efficient management strategy for multi-centric trials. A Steering committee (i.e., co-investigators and co-knowledge users) will meet at strategic decision-making points throughout the trial.</p>
              </sec>
              <sec id="Sec21">
                <title>Dissemination policy</title>
                <p id="Par60">We have adopted an integrated knowledge transfer (KT) strategy in which knowledge users are integral team members and participate in the complete research process. We have established a collaboration with the Relief community organization - involved in the design of the study, full members of the research team, and involved as knowledge users throughout all project phases. Other collaborators, including national, provincial, and regional decision makers, clinicians, and patient-partners for the advisory board, will also contribute specific expertise to integrated knowledge application. All knowledge users will be involved in making decisions concerning data collection, analyses, interpretation of results and knowledge transfer. The detailed KT plan for the study will include activities for the public, organizations/professionals, and scientific community. We will follow best practices recommended by scientific journals to determine authorship in publications.</p>
              </sec>
              <sec id="Sec22">
                <title>Monitoring Steering committee</title>
                <p id="Par61">The study will be overseen by an independent data and safety monitoring committee (DSMC) consisting of three members with collective expertise in statistics, health services research, and anxiety disorders. No interim analyses will be conducted. The Data Safety and Monitoring Committee (DSMC) could request allocation data for a specific participant in case of an incident. The DSMC will monitor patient recruitment, retention and adverse events using a prespecified adverse event reporting protocol. The DSMC will also conduct a semi-annual audit.</p>
              </sec>
            </sec>
            <sec id="Sec23">
              <title>Discussion</title>
              <p id="Par62">To our knowledge, this is the first randomized controlled trial to examine the effectiveness of a structured group SMS program specifically developed for anxiety disorders as a complement to usual care. The SMS intervention developed by Relief for anxiety disorders could promote personal recovery through psychoeducation, strategies for day-to-day symptoms management, self-efficacy and empowerment. In response to the knowledge gap about the added value of structured group SMS for anxiety disorders in community-based care, we have established a strong collaboration between researchers and knowledge users to address this question. This partnership will help us provide relevant data to knowledge users to increase the uptake of trial results. In Québec, this group-based SMS program for anxiety disorders developed and implemented by Relief has demonstrated good uptake, even without evidence-based data regarding the benefits of SMS as a complementary intervention for individuals with anxiety disorders. Moderator and mediator analysis will also provide informative hypothesis generating data for future trials to examine sociodemographic and clinical characteristics associated with SMS effectiveness, but also with regards to previous treatment experience. As there is an overlap between SMS and low-intensity psychotherapy interventions, this may provide interesting health services research hypothesis to inform future studies. Therefore, we will conduct this pragmatic randomized controlled trial to document potential benefits of SMS for individuals experiencing anxiety disorders with extensive patient-reported outcome measures as well as with health system data to inform policy makers, health care managers, clinicians, and patients on the potential impact of the intervention. The Relief community organization is committed to submitting the added value of the group SMS program to a rigorous evaluation, to share results to partner organizations as well as to review the methodology and content of the SMS intervention in case of negative results. A rigorous evaluation of the effectiveness and cost-effectiveness of SMS as a complement to treatment-as-usual could have a significant impact on evidence-based decision-making of stakeholders considering the upward emphasis on a personal recovery-based approach in mental health.</p>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>AFD</term>
                  <def>
                    <p id="Par7">Anxiety-free days</p>
                  </def>
                </def-item>
                <def-item>
                  <term>AQol-6D</term>
                  <def>
                    <p id="Par8">Assessment of Quality of Life – 6D</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BAI</term>
                  <def>
                    <p id="Par9">Beck Anxiety Inventory</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BDCU</term>
                  <def>
                    <p id="Par10">Quebec emergency department database</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CBT</term>
                  <def>
                    <p id="Par11">Cognitive behavioural therapy</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CRCHUS</term>
                  <def>
                    <p id="Par12">Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DSM-5</term>
                  <def>
                    <p id="Par13">Diagnostic and Statistical Manual of Mental Disorders, 5th edition</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DSMC</term>
                  <def>
                    <p id="Par14">Data and safety monitoring committee</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GAD-7</term>
                  <def>
                    <p id="Par15">Generalised Anxiety Disorder Questionnaire</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GCS</term>
                  <def>
                    <p id="Par16">Gross Cohesion Scale</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GLM</term>
                  <def>
                    <p id="Par17">Generalized linear models</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ICER</term>
                  <def>
                    <p id="Par18">Incremental cost-effectiveness ratios</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ICUR</term>
                  <def>
                    <p id="Par19">Incremental cost-utility ratios</p>
                  </def>
                </def-item>
                <def-item>
                  <term>KT</term>
                  <def>
                    <p id="Par20">Knowledge transfer</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MHSQ</term>
                  <def>
                    <p id="Par21">Mental Health Self-Management Questionnaire</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MINI</term>
                  <def>
                    <p id="Par22">Mini International Neuropsychiatric Interview</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PDSS-SR</term>
                  <def>
                    <p id="Par23">Panic Disorder Severity Scale Self Report</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PHQ-9</term>
                  <def>
                    <p id="Par24">Patient Health Questionnaire</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RAMQ</term>
                  <def>
                    <p id="Par25">Régie de l’assurance-maladie du Québec</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RAS-r</term>
                  <def>
                    <p id="Par26">Recovery Assessment Scale – revised</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RCT</term>
                  <def>
                    <p id="Par27">Randomized controlled trial</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SMS</term>
                  <def>
                    <p id="Par28">Self-management support</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SPIN</term>
                  <def>
                    <p id="Par29">Social Phobia Inventory</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TAU</term>
                  <def>
                    <p id="Par30">Treatment-as-usual</p>
                  </def>
                </def-item>
                <def-item>
                  <term>WAI</term>
                  <def>
                    <p id="Par31">Working Alliance Inventory</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>Thank you to Bruno Collard (2009-2019) and Danielle Germain, respectively past and current clinical director at Relief, for their contribution to the trial protocol. Thank you to Pierre Cardinal, patient partner, for sharing advice on trial development.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>PR and JH had the initial idea for this study, and the SMS intervention was developed by JH and Relief. PR prepared the first draft of the paper; JH, JRP and SC revised the first version of the study protocol thoroughly. All authors, including PR, JH, JRP, SC, AB, PB, FCL, MD, MSD, CH, MDP and HMV, have contributed to the design of the clinical trial, and have also critically revised and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>The Canadian Institutes of Health Research funded this study (CIHR grant #169163). The CIHR has no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results. Relief will provide in-kind support to the trial and will participate in specific aspects of the execution of the trial, including training of facilitators and management of the SMS platform. Relief will not be involved in the decision to submit results for publication.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The datasets generated during the current study will not be publicly available due to ethics committee regulations, but will be available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar8">
                <title>Ethics approval and consent to participate</title>
                <p id="Par63">Study approval was given on September 27th, 2021, by the institutional Research Ethics Board (Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre hospitalier universitaire de Sherbrooke, reference number 2022–4191). The REB approved online and verbal consent procedures given the Internet-based data collection strategies; informed consent material is available on request from the corresponding author.</p>
              </notes>
              <notes id="FPar9">
                <title>Consent for publication</title>
                <p id="Par64">Not applicable.</p>
              </notes>
              <notes id="FPar10" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par65">Relief is a non-profit organization whose mission is to support people living with anxiety, depression or bipolarity, and their loved ones, so they can keep moving forward. Relief has developed the group self-management support intervention for anxiety disorders.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Katzman</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Bleau</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Blier</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Chokka</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kjernisted</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Van Ameringen</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <issue>Suppl 1</issue>
                  <fpage>S1</fpage>
                  <lpage>S83</lpage>
                  <pub-id pub-id-type="doi">10.1186/1471-244x-14-s1-s1</pub-id>
                  <?supplied-pmid 25081580?>
                  <pub-id pub-id-type="pmid">25081580</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>American Psychiatric Association</collab>
                  </person-group>
                  <source>Diagnostic and statistical manual of mental disorders</source>
                  <year>2013</year>
                  <edition>5</edition>
                  <publisher-loc>Arlington</publisher-loc>
                  <publisher-name>American Psychiatric Publishing</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barlow</surname>
                      <given-names>DH</given-names>
                    </name>
                  </person-group>
                  <source>Anxiety and its disorders. The nature and treatment of anxiety and panic</source>
                  <year>2002</year>
                  <publisher-loc>NY</publisher-loc>
                  <publisher-name>The Guilford Press</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kessler</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Ruscio</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Shear</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Wittchen</surname>
                      <given-names>HU</given-names>
                    </name>
                  </person-group>
                  <article-title>Epidemiology of anxiety disorders</article-title>
                  <source>Curr Top Behav Neurosci</source>
                  <year>2010</year>
                  <volume>2</volume>
                  <fpage>21</fpage>
                  <lpage>35</lpage>
                  <pub-id pub-id-type="doi">10.1007/7854_2009_9</pub-id>
                  <pub-id pub-id-type="pmid">21309104</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brown</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Campbell</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Lehman</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Grisham</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Mancill</surname>
                      <given-names>RB</given-names>
                    </name>
                  </person-group>
                  <article-title>Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample</article-title>
                  <source>J Abnorm Psychol</source>
                  <year>2001</year>
                  <volume>110</volume>
                  <issue>4</issue>
                  <fpage>585</fpage>
                  <lpage>599</lpage>
                  <pub-id pub-id-type="doi">10.1037//0021-843x.110.4.585</pub-id>
                  <?supplied-pmid 11727948?>
                  <pub-id pub-id-type="pmid">11727948</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lamers</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>van Oppen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Comijs</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Smit</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Spinhoven</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>van Balkom</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA)</article-title>
                  <source>J Clin Psychiat</source>
                  <year>2011</year>
                  <volume>72</volume>
                  <issue>3</issue>
                  <fpage>341</fpage>
                  <lpage>348</lpage>
                  <pub-id pub-id-type="doi">10.4088/JCP.10m06176blu</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Conway</surname>
                      <given-names>KP</given-names>
                    </name>
                    <name>
                      <surname>Compton</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Stinson</surname>
                      <given-names>FS</given-names>
                    </name>
                    <name>
                      <surname>Grant</surname>
                      <given-names>BF</given-names>
                    </name>
                  </person-group>
                  <article-title>Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions</article-title>
                  <source>J Clin Psychiat</source>
                  <year>2006</year>
                  <volume>67</volume>
                  <issue>2</issue>
                  <fpage>247</fpage>
                  <lpage>257</lpage>
                  <pub-id pub-id-type="doi">10.4088/jcp.v67n0211</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roy-Byrne</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Davidson</surname>
                      <given-names>KW</given-names>
                    </name>
                    <name>
                      <surname>Kessler</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Asmundson</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Goodwin</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Kubzansky</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Anxiety disorders and comorbid medical illness</article-title>
                  <source>Gen Hosp Psychiatry</source>
                  <year>2008</year>
                  <volume>30</volume>
                  <issue>3</issue>
                  <fpage>208</fpage>
                  <lpage>225</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.genhosppsych.2007.12.006</pub-id>
                  <?supplied-pmid 18433653?>
                  <pub-id pub-id-type="pmid">18433653</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kroenke</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Monahan</surname>
                      <given-names>PO</given-names>
                    </name>
                    <name>
                      <surname>Lowe</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection</article-title>
                  <source>Ann Intern Med</source>
                  <year>2007</year>
                  <volume>146</volume>
                  <issue>5</issue>
                  <fpage>317</fpage>
                  <lpage>325</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-146-5-200703060-00004</pub-id>
                  <?supplied-pmid 17339617?>
                  <pub-id pub-id-type="pmid">17339617</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Greenberg</surname>
                      <given-names>PE</given-names>
                    </name>
                    <name>
                      <surname>Sisitsky</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Kessler</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Finkelstein</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Berndt</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Davidson</surname>
                      <given-names>JR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The economic burden of anxiety disorders in the 1990s</article-title>
                  <source>J Clin Psychiat</source>
                  <year>1999</year>
                  <volume>60</volume>
                  <issue>7</issue>
                  <fpage>427</fpage>
                  <lpage>435</lpage>
                  <pub-id pub-id-type="doi">10.4088/jcp.v60n0702</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McLean</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Asnaani</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Litz</surname>
                      <given-names>BT</given-names>
                    </name>
                    <name>
                      <surname>Hofmann</surname>
                      <given-names>SG</given-names>
                    </name>
                  </person-group>
                  <article-title>Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness</article-title>
                  <source>J Psychiatr Res</source>
                  <year>2011</year>
                  <volume>45</volume>
                  <issue>8</issue>
                  <fpage>1027</fpage>
                  <lpage>1035</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpsychires.2011.03.006</pub-id>
                  <?supplied-pmid 21439576?>
                  <pub-id pub-id-type="pmid">21439576</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wiebenga</surname>
                      <given-names>JXM</given-names>
                    </name>
                    <name>
                      <surname>Dickhoff</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Merelle</surname>
                      <given-names>SYM</given-names>
                    </name>
                    <name>
                      <surname>Eikelenboom</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Heering</surname>
                      <given-names>HD</given-names>
                    </name>
                    <name>
                      <surname>Gilissen</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence, course, and determinants of suicide ideation and attempts in patients with a depressive and/or anxiety disorder: A review of NESDA findings</article-title>
                  <source>J Affect Disord</source>
                  <year>2021</year>
                  <volume>283</volume>
                  <fpage>267</fpage>
                  <lpage>277</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2021.01.053</pub-id>
                  <?supplied-pmid 33571797?>
                  <pub-id pub-id-type="pmid">33571797</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Fournier</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Duhoux</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>CT</given-names>
                    </name>
                    <name>
                      <surname>Smolders</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Mental health service use and treatment adequacy for anxiety disorders in Canada</article-title>
                  <source>Soc Psychiatry Psychiatr Epidemiol</source>
                  <year>2011</year>
                  <volume>46</volume>
                  <issue>4</issue>
                  <fpage>321</fpage>
                  <lpage>330</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00127-010-0186-2</pub-id>
                  <?supplied-pmid 20217041?>
                  <pub-id pub-id-type="pmid">20217041</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baxter</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Vos</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Scott</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Ferrari</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Whiteford</surname>
                      <given-names>HA</given-names>
                    </name>
                  </person-group>
                  <article-title>The global burden of anxiety disorders in 2010</article-title>
                  <source>Psychol Med</source>
                  <year>2014</year>
                  <volume>44</volume>
                  <issue>11</issue>
                  <fpage>2363</fpage>
                  <lpage>2374</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0033291713003243</pub-id>
                  <?supplied-pmid 24451993?>
                  <pub-id pub-id-type="pmid">24451993</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>National Institute for Health and Care Excellence (NICE)</collab>
                  </person-group>
                  <source>Common mental health disorders. Identification and pathway to care</source>
                  <year>2011</year>
                  <publisher-loc>London</publisher-loc>
                  <publisher-name>The British Psychological Society and The Royal College of Psychiatrists</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Durham</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Higgins</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Chambers</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Swan</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Dow</surname>
                      <given-names>MG</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-term outcome of eight clinical trials of CBT for anxiety disorders: symptom profile of sustained recovery and treatment-resistant groups</article-title>
                  <source>J Affect Disord</source>
                  <year>2012</year>
                  <volume>136</volume>
                  <issue>3</issue>
                  <fpage>875</fpage>
                  <lpage>881</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2011.09.017</pub-id>
                  <?supplied-pmid 22014916?>
                  <pub-id pub-id-type="pmid">22014916</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yonkers</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Bruce</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Dyck</surname>
                      <given-names>IR</given-names>
                    </name>
                    <name>
                      <surname>Keller</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <article-title>Chronicity, relapse, and illness-course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up</article-title>
                  <source>Depress Anxiety</source>
                  <year>2003</year>
                  <volume>17</volume>
                  <issue>3</issue>
                  <fpage>173</fpage>
                  <lpage>179</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.10106</pub-id>
                  <?supplied-pmid 12768651?>
                  <pub-id pub-id-type="pmid">12768651</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Dis</surname>
                      <given-names>EAM</given-names>
                    </name>
                    <name>
                      <surname>van Veen</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Hagenaars</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Batelaan</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>Bockting</surname>
                      <given-names>CLH</given-names>
                    </name>
                    <name>
                      <surname>van den Heuvel</surname>
                      <given-names>RM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis</article-title>
                  <source>JAMA Psychiatry</source>
                  <year>2020</year>
                  <volume>77</volume>
                  <issue>3</issue>
                  <fpage>265</fpage>
                  <lpage>273</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.3986</pub-id>
                  <?supplied-pmid 31758858?>
                  <pub-id pub-id-type="pmid">31758858</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Batelaan</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>Bosman</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Muntingh</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Scholten</surname>
                      <given-names>WD</given-names>
                    </name>
                    <name>
                      <surname>Huijbregts</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>van Balkom</surname>
                      <given-names>AJLM</given-names>
                    </name>
                  </person-group>
                  <article-title>Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials</article-title>
                  <source>BMJ.</source>
                  <year>2017</year>
                  <volume>358</volume>
                  <fpage>j3927</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.j3927</pub-id>
                  <?supplied-pmid 28903922?>
                  <pub-id pub-id-type="pmid">28903922</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levy</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>O'Bryan</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Tolin</surname>
                      <given-names>DF</given-names>
                    </name>
                  </person-group>
                  <article-title>A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders</article-title>
                  <source>J Anxiety Disord</source>
                  <year>2021</year>
                  <volume>81</volume>
                  <fpage>102407</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.janxdis.2021.102407</pub-id>
                  <?supplied-pmid 33915506?>
                  <pub-id pub-id-type="pmid">33915506</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rodriguez</surname>
                      <given-names>BF</given-names>
                    </name>
                    <name>
                      <surname>Weisberg</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Pagano</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Bruce</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Spencer</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Culpepper</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients</article-title>
                  <source>J Nerv Ment Dis</source>
                  <year>2006</year>
                  <volume>194</volume>
                  <issue>2</issue>
                  <fpage>91</fpage>
                  <lpage>97</lpage>
                  <pub-id pub-id-type="doi">10.1097/01.nmd.0000198140.02154.32</pub-id>
                  <?supplied-pmid 16477186?>
                  <pub-id pub-id-type="pmid">16477186</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kelly</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Mezuk</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictors of remission from generalized anxiety disorder and major depressive disorder</article-title>
                  <source>J Affect Disord</source>
                  <year>2017</year>
                  <volume>208</volume>
                  <fpage>467</fpage>
                  <lpage>474</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2016.10.042</pub-id>
                  <?supplied-pmid 27863710?>
                  <pub-id pub-id-type="pmid">27863710</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coulombe</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Radziszewski</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Trepanier</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Provencher</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hudon</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mental health self-management questionnaire: Development and psychometric properties</article-title>
                  <source>J Affect Disord</source>
                  <year>2015</year>
                  <volume>181</volume>
                  <fpage>41</fpage>
                  <lpage>49</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2015.04.007</pub-id>
                  <?supplied-pmid 25917292?>
                  <pub-id pub-id-type="pmid">25917292</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coulombe</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Radziszewski</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Meunier</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Provencher</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Hudon</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Profiles of recovery from mood and anxiety disorders: A person-centered exploration of people's engagement in self-management</article-title>
                  <source>Front Psychol</source>
                  <year>2016</year>
                  <volume>7</volume>
                  <fpage>584</fpage>
                  <pub-id pub-id-type="doi">10.3389/fpsyg.2016.00584</pub-id>
                  <?supplied-pmid 27199819?>
                  <pub-id pub-id-type="pmid">27199819</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Houle</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gascon-Depatie</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Belanger-Dumontier</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Cardinal</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Depression self-management support: a systematic review</article-title>
                  <source>Patient Educ Couns</source>
                  <year>2013</year>
                  <volume>91</volume>
                  <issue>3</issue>
                  <fpage>271</fpage>
                  <lpage>279</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.pec.2013.01.012</pub-id>
                  <?supplied-pmid 23414831?>
                  <pub-id pub-id-type="pmid">23414831</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anthony</surname>
                      <given-names>WA</given-names>
                    </name>
                  </person-group>
                  <article-title>Recovery from mental illness: The guiding vision of the mental health service system in the 1990s</article-title>
                  <source>Psychosoc Rehabil J</source>
                  <year>1993</year>
                  <volume>16</volume>
                  <issue>4</issue>
                  <fpage>11</fpage>
                  <lpage>23</lpage>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coleman</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Austin</surname>
                      <given-names>BT</given-names>
                    </name>
                    <name>
                      <surname>Brach</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Wagner</surname>
                      <given-names>EH</given-names>
                    </name>
                  </person-group>
                  <article-title>Evidence on the Chronic Care Model in the new millennium</article-title>
                  <source>Health Aff</source>
                  <year>2009</year>
                  <volume>28</volume>
                  <issue>1</issue>
                  <fpage>75</fpage>
                  <lpage>85</lpage>
                  <pub-id pub-id-type="doi">10.1377/hlthaff.28.1.75</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Corrigan</surname>
                      <given-names>PW</given-names>
                    </name>
                  </person-group>
                  <source>Person-centered care for mental illness: The evolution of adherence and self-determination</source>
                  <year>2015</year>
                  <publisher-loc>Washington, DC</publisher-loc>
                  <publisher-name>American Psychological Association</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Panagioti</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Richardson</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Small</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Rogers</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis</article-title>
                  <source>BMC Health Serv Res</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>356</fpage>
                  <pub-id pub-id-type="doi">10.1186/1472-6963-14-356</pub-id>
                  <?supplied-pmid 25164529?>
                  <pub-id pub-id-type="pmid">25164529</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>Mental Health Commission of Canada</collab>
                  </person-group>
                  <source>Guidelines for recovery-oriented practice</source>
                  <year>2015</year>
                  <publisher-loc>Ottawa</publisher-loc>
                  <publisher-name>Mental Health Commission of Canada</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Villaggi</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Provencher</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Coulombe</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Meunier</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Radziszewski</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hudon</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Self-management strategies in recovery from mood and anxiety disorders</article-title>
                  <source>Glob Qual Nurs Res</source>
                  <year>2015</year>
                  <volume>2</volume>
                  <fpage>1</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1177/2333393615606092</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brady</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>O’Colmain</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Beauchesne</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Daniels</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Greenberg</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A Meta-Analysis of Health Status, Health Behaviors, and Health Care Utilization Outcomes of the Chronic Disease Self-Management Program</article-title>
                  <source>Prev Chronic Dis</source>
                  <year>2013</year>
                  <volume>10</volume>
                  <fpage>120112</fpage>
                  <pub-id pub-id-type="doi">10.5888/pcd10.120112</pub-id>
                  <?supplied-pmid 23327828?>
                  <pub-id pub-id-type="pmid">23327828</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cook</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Copeland</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Jonikas</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Razzano</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Floyd</surname>
                      <given-names>CB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Initial outcomes of a mental illness self-management program based on wellness recovery action planning</article-title>
                  <source>Psychiatr Serv</source>
                  <year>2009</year>
                  <volume>60</volume>
                  <issue>2</issue>
                  <fpage>246</fpage>
                  <lpage>249</lpage>
                  <pub-id pub-id-type="doi">10.1176/appi.ps.60.2.246</pub-id>
                  <?supplied-pmid 19176420?>
                  <pub-id pub-id-type="pmid">19176420</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lorig</surname>
                      <given-names>KR</given-names>
                    </name>
                    <name>
                      <surname>Ritter</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Pifer</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Werner</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Effectiveness of the chronic disease self-management program for persons with a serious mental illness: a translation study</article-title>
                  <source>Community Ment Health J</source>
                  <year>2014</year>
                  <volume>50</volume>
                  <issue>1</issue>
                  <fpage>96</fpage>
                  <lpage>103</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10597-013-9615-5</pub-id>
                  <?supplied-pmid 23748554?>
                  <pub-id pub-id-type="pmid">23748554</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Houle</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gauvin</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Collard</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Meunier</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Frasure-Smith</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Lespérance</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Empowering Adults in Recovery from Depression: A Community- Based Self-Management Group Program</article-title>
                  <source>Can J Commun Ment Health</source>
                  <year>2016</year>
                  <volume>35</volume>
                  <issue>2</issue>
                  <fpage>55</fpage>
                  <lpage>68</lpage>
                  <pub-id pub-id-type="doi">10.7870/cjcmh-2016-033</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lam</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>McIntosh</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Enns</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Kolivakis</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Michalak</surname>
                      <given-names>EE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care</article-title>
                  <source>Can J Psychiatr</source>
                  <year>2016</year>
                  <volume>61</volume>
                  <issue>9</issue>
                  <fpage>510</fpage>
                  <lpage>523</lpage>
                  <pub-id pub-id-type="doi">10.1177/0706743716659416</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cook</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Copeland</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Floyd</surname>
                      <given-names>CB</given-names>
                    </name>
                    <name>
                      <surname>Jonikas</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Razzano</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A randomized controlled trial of effects of Wellness Recovery Action Planning on depression, anxiety, and recovery</article-title>
                  <source>Psychiatr Serv</source>
                  <year>2012</year>
                  <volume>63</volume>
                  <issue>6</issue>
                  <fpage>541</fpage>
                  <lpage>547</lpage>
                  <pub-id pub-id-type="doi">10.1176/appi.ps.201100125</pub-id>
                  <?supplied-pmid 22508435?>
                  <pub-id pub-id-type="pmid">22508435</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zimmermann</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Puschmann</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>van den Bussche</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wiese</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Ernst</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Porzelt</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: Cluster-randomised controlled trial (findings of the SMADS study)</article-title>
                  <source>Int J Nurs Stud</source>
                  <year>2016</year>
                  <volume>63</volume>
                  <fpage>101</fpage>
                  <lpage>111</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijnurstu.2016.08.007</pub-id>
                  <?supplied-pmid 27611093?>
                  <pub-id pub-id-type="pmid">27611093</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zoun</surname>
                      <given-names>MHH</given-names>
                    </name>
                    <name>
                      <surname>Koekkoek</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Sinnema</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>van der Feltz-Cornelis</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>van Balkom</surname>
                      <given-names>AJLM</given-names>
                    </name>
                    <name>
                      <surname>Schene</surname>
                      <given-names>AH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders on quality of life, symptoms, and empowerment: results of a randomized controlled trial</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2019</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>46</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12888-019-2013-y</pub-id>
                  <?supplied-pmid 30691421?>
                  <pub-id pub-id-type="pmid">30691421</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chan</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Tetzlaff</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Altman</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Laupacis</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gotzsche</surname>
                      <given-names>PC</given-names>
                    </name>
                    <name>
                      <surname>Krleza-Jeric</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title>
                  <source>Ann Intern Med</source>
                  <year>2013</year>
                  <volume>158</volume>
                  <issue>3</issue>
                  <fpage>200</fpage>
                  <lpage>207</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-158-3-201302050-00583</pub-id>
                  <?supplied-pmid 23295957?>
                  <pub-id pub-id-type="pmid">23295957</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sheehan</surname>
                      <given-names>DV</given-names>
                    </name>
                    <name>
                      <surname>Lecrubier</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sheehan</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Amorim</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Janavs</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Weiller</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>
                  <source>J Clin Psychiatry</source>
                  <year>1998</year>
                  <volume>59</volume>
                  <issue>Suppl 20</issue>
                  <fpage>22</fpage>
                  <lpage>33</lpage>
                  <?supplied-pmid 9881538?>
                  <pub-id pub-id-type="pmid">9881538</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <mixed-citation publication-type="other">Cyr C, McKee H, O’Hagan M, Priest R, for the Mental Health Commission of Canada. Making the case for peer support: Report to the Peer Support Project Committee of the Mental Health Commission of Canada(2010 first edition / 2016 second edition). Available from: Retrieved from: <ext-link ext-link-type="uri" xlink:href="http://www.mentalhealthcommission.ca">http://www.mentalhealthcommission.ca</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mead</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hilton</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Peer support: a theoretical perspective</article-title>
                  <source>Psychiatr Rehabil J</source>
                  <year>2001</year>
                  <volume>25</volume>
                  <issue>2</issue>
                  <fpage>134</fpage>
                  <lpage>141</lpage>
                  <pub-id pub-id-type="doi">10.1037/h0095032</pub-id>
                  <pub-id pub-id-type="pmid">11769979</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Solomon</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Peer support/peer provided services underlying processes, benefits, and critical ingredients</article-title>
                  <source>Psychiatr Rehabil J</source>
                  <year>2004</year>
                  <volume>27</volume>
                  <issue>4</issue>
                  <fpage>392</fpage>
                  <lpage>401</lpage>
                  <pub-id pub-id-type="doi">10.2975/27.2004.392.401</pub-id>
                  <pub-id pub-id-type="pmid">15222150</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Kroenke</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Lowe</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title>
                  <source>Arch Intern Med</source>
                  <year>2006</year>
                  <volume>166</volume>
                  <issue>10</issue>
                  <fpage>1092</fpage>
                  <lpage>1097</lpage>
                  <pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id>
                  <?supplied-pmid 16717171?>
                  <pub-id pub-id-type="pmid">16717171</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Connor</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Davidson</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Churchill</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Sherwood</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Foa</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Weisler</surname>
                      <given-names>RH</given-names>
                    </name>
                  </person-group>
                  <article-title>Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale</article-title>
                  <source>Br J Psychiatry</source>
                  <year>2000</year>
                  <volume>176</volume>
                  <fpage>379</fpage>
                  <lpage>386</lpage>
                  <pub-id pub-id-type="doi">10.1192/bjp.176.4.379</pub-id>
                  <?supplied-pmid 10827888?>
                  <pub-id pub-id-type="pmid">10827888</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Radomsky</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Ashbaugh</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Saxe</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Ouimet</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Golden</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Lavoie</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>O'Connor</surname>
                      <given-names>KP</given-names>
                    </name>
                  </person-group>
                  <article-title>Psychometric Properties of the French and English Versions of the Social Phobia Inventory</article-title>
                  <source>Can J Behav Sci</source>
                  <year>2006</year>
                  <volume>38</volume>
                  <issue>4</issue>
                  <fpage>354</fpage>
                  <lpage>360</lpage>
                  <pub-id pub-id-type="doi">10.1037/cjbs2006021</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Houck</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Spiegel</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Shear</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Rucci</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Reliability of the self-report version of the panic disorder severity scale</article-title>
                  <source>Depress Anxiety</source>
                  <year>2002</year>
                  <volume>15</volume>
                  <issue>4</issue>
                  <fpage>183</fpage>
                  <lpage>185</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.10049</pub-id>
                  <?supplied-pmid 12112724?>
                  <pub-id pub-id-type="pmid">12112724</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beck</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Epstein</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <article-title>An inventory for measuring clinical anxiety: psychometric properties</article-title>
                  <source>J Consult Clin Psychol</source>
                  <year>1988</year>
                  <volume>56</volume>
                  <issue>6</issue>
                  <fpage>893</fpage>
                  <lpage>897</lpage>
                  <pub-id pub-id-type="doi">10.1037/0022-006X.56.6.893</pub-id>
                  <pub-id pub-id-type="pmid">3204199</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Freeston</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Ladouceur</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Thibodeau</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Gagnon</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Rheaume</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>The Beck Anxiety Inventory. Psychometric properties of a French translation</article-title>
                  <source>Encephale.</source>
                  <year>1994</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>47</fpage>
                  <lpage>55</lpage>
                  <?supplied-pmid 8174510?>
                  <pub-id pub-id-type="pmid">8174510</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oei</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>McAlinden</surname>
                      <given-names>NM</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in quality of life following group CBT for anxiety and depression in a psychiatric outpatient clinic</article-title>
                  <source>Psychiatry Res</source>
                  <year>2014</year>
                  <volume>220</volume>
                  <issue>3</issue>
                  <fpage>1012</fpage>
                  <lpage>1018</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.psychres.2014.08.036</pub-id>
                  <?supplied-pmid 25256885?>
                  <pub-id pub-id-type="pmid">25256885</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kroenke</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>JB</given-names>
                    </name>
                  </person-group>
                  <article-title>The PHQ-9: validity of a brief depression severity measure</article-title>
                  <source>J Gen Intern Med</source>
                  <year>2001</year>
                  <volume>16</volume>
                  <issue>9</issue>
                  <fpage>606</fpage>
                  <lpage>613</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id>
                  <pub-id pub-id-type="pmid">11556941</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richardson</surname>
                      <given-names>JRJ</given-names>
                    </name>
                    <name>
                      <surname>Peacock</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Hawthorne</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Iezzi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Elsworth</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Day</surname>
                      <given-names>NA</given-names>
                    </name>
                  </person-group>
                  <article-title>Construction of the descriptive system for the assessment of quality of life AQoL-6D utility instrument</article-title>
                  <source>Health Qual Life Outcomes</source>
                  <year>2012</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>38</fpage>
                  <pub-id pub-id-type="doi">10.1186/1477-7525-10-38</pub-id>
                  <?supplied-pmid 22507254?>
                  <pub-id pub-id-type="pmid">22507254</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bayliss</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Ellis</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Steiner</surname>
                      <given-names>JF</given-names>
                    </name>
                  </person-group>
                  <article-title>Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument</article-title>
                  <source>Health Qual Life Outcomes</source>
                  <year>2005</year>
                  <volume>3</volume>
                  <fpage>51</fpage>
                  <pub-id pub-id-type="doi">10.1186/1477-7525-3-51</pub-id>
                  <?supplied-pmid 16137329?>
                  <pub-id pub-id-type="pmid">16137329</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Poitras</surname>
                      <given-names>M-E</given-names>
                    </name>
                    <name>
                      <surname>Fortin</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hudon</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Haggerty</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Almirall</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Validation of the disease burden morbidity assessment by self-report in a French-speaking population</article-title>
                  <source>BMC Health Serv Res</source>
                  <year>2012</year>
                  <volume>12</volume>
                  <fpage>35</fpage>
                  <pub-id pub-id-type="doi">10.1186/1472-6963-12-35</pub-id>
                  <?supplied-pmid 22333434?>
                  <pub-id pub-id-type="pmid">22333434</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Corrigan</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Giffort</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Rashid</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Leary</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Okeke</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Recovery as a psychological construct</article-title>
                  <source>Community Ment Health J</source>
                  <year>1999</year>
                  <volume>35</volume>
                  <issue>3</issue>
                  <fpage>231</fpage>
                  <lpage>239</lpage>
                  <pub-id pub-id-type="doi">10.1023/a:1018741302682</pub-id>
                  <?supplied-pmid 10401893?>
                  <pub-id pub-id-type="pmid">10401893</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Giffort</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Schmook</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Woody</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Vollendorf</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gervain</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <source>Construction of a Scale to Measure Consumer Recovery</source>
                  <year>1995</year>
                  <publisher-loc>Springfield</publisher-loc>
                  <publisher-name>Department of Health and Human Services, Office of Mental Health</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salzer</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Brusilovskiy</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Advancing recovery science: reliability and validity properties of the Recovery Assessment Scale</article-title>
                  <source>Psychiatr Serv</source>
                  <year>2014</year>
                  <volume>65</volume>
                  <issue>4</issue>
                  <fpage>442</fpage>
                  <lpage>453</lpage>
                  <pub-id pub-id-type="doi">10.1176/appi.ps.201300089</pub-id>
                  <?supplied-pmid 24487405?>
                  <pub-id pub-id-type="pmid">24487405</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pelletier</surname>
                      <given-names>J-F</given-names>
                    </name>
                    <name>
                      <surname>Corbière</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lecomte</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Briand</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Corrigan</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Davidson</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Citizenship and recovery: two intertwined concepts for civic-recovery</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2015</year>
                  <volume>15</volume>
                  <issue>1</issue>
                  <fpage>37</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12888-015-0420-2</pub-id>
                  <?supplied-pmid 25885779?>
                  <pub-id pub-id-type="pmid">25885779</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horvath</surname>
                      <given-names>AO</given-names>
                    </name>
                    <name>
                      <surname>Greenberg</surname>
                      <given-names>LS</given-names>
                    </name>
                  </person-group>
                  <article-title>Development and validation of the Working Alliance Inventory</article-title>
                  <source>J Couns Psychol</source>
                  <year>1989</year>
                  <volume>36</volume>
                  <issue>2</issue>
                  <fpage>223</fpage>
                  <lpage>233</lpage>
                  <pub-id pub-id-type="doi">10.1037/0022-0167.36.2.223</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Corbiere</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bisson</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lauzon</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ricard</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Factorial validation of a French short-form of the Working Alliance Inventory</article-title>
                  <source>Int J Methods Psychiatr Res</source>
                  <year>2006</year>
                  <volume>15</volume>
                  <issue>1</issue>
                  <fpage>36</fpage>
                  <lpage>45</lpage>
                  <pub-id pub-id-type="doi">10.1002/mpr.27</pub-id>
                  <pub-id pub-id-type="pmid">16676684</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tracey</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Kokotovic</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>Factor structure of the working alliance inventory</article-title>
                  <source>Psychol Assess</source>
                  <year>1989</year>
                  <volume>1</volume>
                  <issue>3</issue>
                  <fpage>207</fpage>
                  <lpage>210</lpage>
                  <pub-id pub-id-type="doi">10.1037/1040-3590.1.3.207</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stokes</surname>
                      <given-names>JP</given-names>
                    </name>
                  </person-group>
                  <article-title>Toward an understanding of cohesion in personal change groups</article-title>
                  <source>Int J Group Psychother</source>
                  <year>1983</year>
                  <volume>33</volume>
                  <fpage>449</fpage>
                  <lpage>467</lpage>
                  <pub-id pub-id-type="doi">10.1080/00207284.1983.11491345</pub-id>
                  <pub-id pub-id-type="pmid">6642805</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Creswell</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Plano Clark</surname>
                      <given-names>VL</given-names>
                    </name>
                  </person-group>
                  <source>Designing and Conducting Mixed Methods Research</source>
                  <year>2017</year>
                  <edition>3</edition>
                  <publisher-loc>Thousand Oaks</publisher-loc>
                  <publisher-name>SAGE Publications</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patton</surname>
                      <given-names>MQ</given-names>
                    </name>
                  </person-group>
                  <source>Qualitative Research &amp; Evaluation Methods</source>
                  <year>2014</year>
                  <edition>4</edition>
                  <publisher-loc>Thousand Oaks</publisher-loc>
                  <publisher-name>SAGE Publications</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miles</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Huberman</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Saldana</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <source>Qualitative Data Analysis: a Methods Sourcebook</source>
                  <year>2014</year>
                  <edition>3</edition>
                  <publisher-loc>Thousand Oaks</publisher-loc>
                  <publisher-name>SAGE Publications</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>QSR International Pty Ltd</collab>
                  </person-group>
                  <source>NVivo (Version 12)</source>
                  <year>2018</year>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tango</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>On the repeated measures designs and sample sizes for randomized controlled trials</article-title>
                  <source>Biostatistics.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <issue>2</issue>
                  <fpage>334</fpage>
                  <lpage>349</lpage>
                  <pub-id pub-id-type="doi">10.1093/biostatistics/kxv047</pub-id>
                  <?supplied-pmid 26586845?>
                  <pub-id pub-id-type="pmid">26586845</pub-id>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jacobson</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Truax</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical significance: a statistical approach to defining meaningful change in psychotherapy research</article-title>
                  <source>J Consult Clin Psychol</source>
                  <year>1991</year>
                  <volume>59</volume>
                  <issue>1</issue>
                  <fpage>12</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="doi">10.1037//0022-006x.59.1.12</pub-id>
                  <?supplied-pmid 2002127?>
                  <pub-id pub-id-type="pmid">2002127</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <mixed-citation publication-type="other">Roberge P, Provencher MD, Gaboury I, Gosselin P, Vasiliadis HM, Benoit A, et al. Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial. Psychol Med. 2020:1–11. 10.1017/S0033291720004316.</mixed-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pals</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Alfano</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Shadish</surname>
                      <given-names>WR</given-names>
                    </name>
                    <name>
                      <surname>Hannan</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>WL</given-names>
                    </name>
                  </person-group>
                  <article-title>Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches</article-title>
                  <source>Am J Public Health</source>
                  <year>2008</year>
                  <volume>98</volume>
                  <issue>8</issue>
                  <fpage>1418</fpage>
                  <lpage>1424</lpage>
                  <pub-id pub-id-type="doi">10.2105/AJPH.2007.127027</pub-id>
                  <?supplied-pmid 18556603?>
                  <pub-id pub-id-type="pmid">18556603</pub-id>
                </element-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hooper</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Teerenstra</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>de Hoop</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Eldridge</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Sample size calculation for stepped wedge and other longitudinal cluster randomised trials</article-title>
                  <source>Stat Med</source>
                  <year>2016</year>
                  <volume>35</volume>
                  <issue>26</issue>
                  <fpage>4718</fpage>
                  <lpage>4728</lpage>
                  <pub-id pub-id-type="doi">10.1002/sim.7028</pub-id>
                  <?supplied-pmid 27350420?>
                  <pub-id pub-id-type="pmid">27350420</pub-id>
                </element-citation>
              </ref>
              <ref id="CR73">
                <label>73.</label>
                <mixed-citation publication-type="other">The Shiny CRT Calculator: power and sample size for cluster randomised trials. <ext-link ext-link-type="uri" xlink:href="https://clusterrcts.shinyapps.io/rshinyapp/">https://clusterrcts.shinyapps.io/rshinyapp/</ext-link>. Accessed 27 Oct 2021.</mixed-citation>
              </ref>
              <ref id="CR74">
                <label>74.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Buuren</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Hall</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <source>Flexible Imputation of Missing Data</source>
                  <year>2012</year>
                  <publisher-loc>Boca Raton</publisher-loc>
                  <publisher-name>Taylor &amp; Francis Group</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR75">
                <label>75.</label>
                <mixed-citation publication-type="other">Little RJ, Rubin DB. Statistical analysis with missing data. 3rd ed. Hoboken: John Wiley &amp; Sons; 2019.</mixed-citation>
              </ref>
              <ref id="CR76">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pincus</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Miles</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Froud</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Underwood</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Carnes</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>SJC</given-names>
                    </name>
                  </person-group>
                  <article-title>Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study</article-title>
                  <source>BMC Med Res Methodol</source>
                  <year>2011</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>14</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2288-11-14</pub-id>
                  <?supplied-pmid 21281501?>
                  <pub-id pub-id-type="pmid">21281501</pub-id>
                </element-citation>
              </ref>
              <ref id="CR77">
                <label>77.</label>
                <mixed-citation publication-type="other">Canadian Agency for Drugs and Technologies in Health (CADTH). Canadian guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa: The Canadian Agency for Drugs and Technologies in Health (CADTH); 2006.</mixed-citation>
              </ref>
              <ref id="CR78">
                <label>78.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vasiliadis</surname>
                      <given-names>H-M</given-names>
                    </name>
                    <name>
                      <surname>Latimer</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Dionne</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Préville</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>The costs associated with antidepressant use in depression and anxiety in community-living older adults</article-title>
                  <source>Can J Psychiatr</source>
                  <year>2013</year>
                  <volume>58</volume>
                  <issue>4</issue>
                  <fpage>201</fpage>
                  <lpage>209</lpage>
                  <pub-id pub-id-type="doi">10.1177/070674371305800405</pub-id>
                </element-citation>
              </ref>
              <ref id="CR79">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vasiliadis</surname>
                      <given-names>H-M</given-names>
                    </name>
                    <name>
                      <surname>Briand</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Lesage</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Reinharz</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Stip</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Nicole</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Health care resource use associated with integrated psychological treatment</article-title>
                  <source>J Ment Health Policy Econ</source>
                  <year>2006</year>
                  <volume>9</volume>
                  <issue>4</issue>
                  <fpage>201</fpage>
                  <lpage>207</lpage>
                  <?supplied-pmid 17200597?>
                  <pub-id pub-id-type="pmid">17200597</pub-id>
                </element-citation>
              </ref>
              <ref id="CR80">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lave</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Schulberg</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Kamlet</surname>
                      <given-names>MS</given-names>
                    </name>
                  </person-group>
                  <article-title>Cost-effectiveness of treatments for major depression in primary care practice</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <year>1998</year>
                  <volume>55</volume>
                  <issue>7</issue>
                  <fpage>645</fpage>
                  <lpage>651</lpage>
                  <pub-id pub-id-type="doi">10.1001/archpsyc.55.7.645</pub-id>
                  <?supplied-pmid 9672056?>
                  <pub-id pub-id-type="pmid">9672056</pub-id>
                </element-citation>
              </ref>
              <ref id="CR81">
                <label>81.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richardson</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Khan</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Iezzi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Maxwell</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments</article-title>
                  <source>Med Decis Mak</source>
                  <year>2015</year>
                  <volume>35</volume>
                  <issue>3</issue>
                  <fpage>276</fpage>
                  <lpage>291</lpage>
                  <pub-id pub-id-type="doi">10.1177/0272989x14543107</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
